Longevity Health Inc.

NASDAQ: XAGE · Real-Time Price · USD
2.77
0.07 (2.59%)
At close: Aug 26, 2025, 3:59 PM
2.76
-0.36%
After-hours: Aug 26, 2025, 05:05 PM EDT

Longevity Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Revenue
1.05M 560.67K 50.32K -3.7M 12.32K n/a n/a 3.73M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
447.55K 246.89K 63.93K 62.7K 1.6M 1.6M 1.54M 1.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
604.41K 313.78K -13.61K -3.76M -1.59M -1.6M -1.54M 2.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-5.79M -5.12M -5M -2.04M -5.03M -5M -4.37M -9.12M -5.56M -4.68M -4.46M -2.04M -1.28M -1M -466.23K -96.33K -6.37K
Interest Income
n/a n/a n/a n/a n/a 1.87M 3.54M 4.88M 5.58M 3.71M 2.03M 698.28K n/a n/a n/a n/a n/a
Pretax Income
-7.28M -8.7M -10.75M -7.34M -15.93M -11.91M -7.44M -12.95M -7.56M -8.34M -9.79M -6.91M -929.92K -855.7K -328.17K -93.67K -6.37K
Net Income
-7.19M -8.6M -10.37M -6.3M -14.88M -11.26M -7.41M -13.69M -8.29M -8.95M -10.06M -7.18M -1.2M -855.7K -328.17K -93.67K -6.37K
Selling & General & Admin
5.37M 4.53M 3.9M 69.34K 3.48M 3.56M 3.39M 8.54M 4.3M 3.42M 3.2M 1.45M 1.28M 995K 459.86K 89.96K n/a
Research & Development
946.34K 821.8K 1.05M 126.62K 1.47M 2.19M 2.5M 3.88M 2.78M 1.95M 1.21M 570.93K n/a n/a n/a n/a n/a
Other Expenses
82.56K 83.91K 25.92K -1.92M -1.51M -1.53M -1.46M 463.6K 34.13K 34.59K 48.00 9.00 n/a -6.37K -6.37K -6.37K -6.37K
Operating Expenses
6.4M 5.44M 4.98M -1.72M 3.44M 3.4M 2.83M 11.3M 5.56M 4.68M 4.46M 2.04M 1.28M 988.63K 453.49K 83.59K -6.37K
Interest Expense
22.19K 28.97K 49.02K -6.2K 384.36K 651.05K 889.32K 1.26M 2.36M 2.08M 1.82M 1.49M n/a n/a n/a n/a n/a
Selling & Marketing Expenses
804.33K 469.87K 189.32K -2.94M 11.04K n/a 246.02K 3.32M 246.02K 246.02K n/a -7.58K -7.58K -7.58K -7.58K n/a n/a
Cost & Expenses
6.84M 5.69M 5.05M -1.66M 5.04M 5M 4.37M 12.85M 5.56M 4.68M 4.46M 2.04M 1.28M 988.63K 453.49K 83.59K -6.37K
Income Tax Expense
-97.28K -97.28K -97.28K n/a n/a 388.63K 731.95K 731.95K 731.95K 609.73K 266.41K 266.41K 266.41K n/a n/a n/a n/a
Shares Outstanding (Basic)
1.21M 20.91M 20.91M 20.91M 20.74M 22.92M 20.77M 18.63M 19.77M 19.77M 19.77M 19.24M 19.24M 19.77M 19.77M 19.77M 19.31M
Shares Outstanding (Diluted)
1.21M 20.91M 20.91M 20.91M 20.74M 22.92M 20.77M 18.63M 19.77M 19.77M 19.77M 19.24M 19.24M 19.77M 19.77M 19.77M 19.31M
EPS (Basic)
-1.82 -0.42 -0.55 -0.36 -0.84 -0.66 -0.42 -0.73 -0.43 -0.47 -0.52 -0.38 -0.06 -0.04 -0.02 -0.00 -0.00
EPS (Diluted)
-1.82 -0.42 -0.55 -0.36 -0.84 -0.66 -0.42 -0.73 -0.43 -0.47 -0.52 -0.38 -0.06 -0.04 -0.02 -0.00 -0.00
EBITDA
-7.04M -8.46M -10.5M -7.54M -15.35M -15.14M -13.18M -17.91M -8.09M -5.55M -4.58M -2.08M -1.34M -855.7K -328.17K -93.67K -6.37K
EBIT
-7.26M -8.67M -10.7M -7.35M -15.54M -17.28M -15.32M -20.45M -13.96M -9.21M -8.18M -5.62M -1.14M -849.33K -321.8K -87.3K n/a
Depreciation & Amortization
220.73K 213.4K 197.26K -190.66K 190.26K -1.74M -1.73M -1.32M -1.72M -62.18K -114.48K -32.3K -53.27K 207.83K 200.22K 58.46K 55.81K